Add to ORKGA randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patient
Background: Preclinical studies demonstrate renal proximal tubular injury after administration of so...
Background: Preclinical studies demonstrate renal proximal tubular injury after administration of so...
Copyright © 2013 Iftikhar Hussain et al.This is an open access article distributed under theCreative...
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatme...
Background Patients with non-dialysis-dependent chronic kidney disease (ND-CKD) often receive an ery...
Background and objectives Few randomized controlled trials have compared intravenous iron products h...
Background and objectives Few randomized controlled trials have compared intravenous iron products h...
Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency a...
The evidence base regarding the safety of intravenous (IV) iron therapy in patients with chronic kid...
The evidence base regarding the safety of intravenous (IV) iron therapy in patients with chronic kid...
Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure ...
The optimal iron therapy regimen in patients with non-dialysis-dependent chronic kidney disease (CKD...
Background: The optimal iron therapy regimen in patients with non-dialysis-dependent chronic kidney ...
Background: The evidence base regarding the safety of intravenous (IV) iron therapy in patients with...
Background: The evidence base regarding the safety of intravenous (IV) iron therapy in patients with...
Background: Preclinical studies demonstrate renal proximal tubular injury after administration of so...
Background: Preclinical studies demonstrate renal proximal tubular injury after administration of so...
Copyright © 2013 Iftikhar Hussain et al.This is an open access article distributed under theCreative...
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatme...
Background Patients with non-dialysis-dependent chronic kidney disease (ND-CKD) often receive an ery...
Background and objectives Few randomized controlled trials have compared intravenous iron products h...
Background and objectives Few randomized controlled trials have compared intravenous iron products h...
Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency a...
The evidence base regarding the safety of intravenous (IV) iron therapy in patients with chronic kid...
The evidence base regarding the safety of intravenous (IV) iron therapy in patients with chronic kid...
Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure ...
The optimal iron therapy regimen in patients with non-dialysis-dependent chronic kidney disease (CKD...
Background: The optimal iron therapy regimen in patients with non-dialysis-dependent chronic kidney ...
Background: The evidence base regarding the safety of intravenous (IV) iron therapy in patients with...
Background: The evidence base regarding the safety of intravenous (IV) iron therapy in patients with...
Background: Preclinical studies demonstrate renal proximal tubular injury after administration of so...
Background: Preclinical studies demonstrate renal proximal tubular injury after administration of so...
Copyright © 2013 Iftikhar Hussain et al.This is an open access article distributed under theCreative...